Home / Guides / Compounded vs. brand-name tirzepatide
Two different products. One clear choice for you.
Compounded vs brand-name tirzepatide (Zepbound): FDA status, price and which fits you
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated
Zepbound is FDA-approved brand-name tirzepatide, $299 to $449 a month at LillyDirect (checked November 1, 2026). LillyDirect’s $449 (7.5 to 15 mg) needs a refill within 45 days, or it’s $499 to $699. Compounded tirzepatide, made by a state-licensed pharmacy for your prescription, isn’t FDA-approved; at NexLife, $139 on the 12-month plan or $169 month to month.
$139/mo on 12 months, every dosePrice Match Guarantee†
- Zepbound: FDA-approved, $299 to $449 a month at LillyDirect ($449, from 7.5 mg, needs a refill within 45 days; otherwise $499 to $699)
- Compounded: not FDA-approved, $139 to $399 a month online in our price index
- Generic? None exists in the U.S.
Compounded tirzepatide vs. Zepbound, in short
- Who makes it?
- Zepbound: Eli Lilly; compounded: a state-licensed pharmacy
- FDA-approved?
- Zepbound yes; compounded no
- Studied in trials?
- Zepbound yes; compounded no
- Self-pay price
- Zepbound $299 to $449 ($449, from 7.5 mg, needs a refill within 45 days; otherwise $499 to $699); NexLife $139 on 12 months, or $169 month to month
- Generic?
- No FDA-approved generic exists
Not sure which fits you? Call or text
4.8 out of 5 on Trustpilot · LegitScript certified
About 3 minutes of health questions. No insurance needed.
Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.
The differences
What’s the difference between compounded and brand-name tirzepatide?
| Compounded tirzepatide | Zepbound (brand-name) | |
|---|---|---|
| FDA-approved? | No | Yes |
| Who makes it | A state-licensed pharmacy, for your prescription | Eli Lilly and Company |
| Form and formula | A multiple-dose vial you draw with a syringe; the formula can differ by pharmacy and may include an added vitamin | Pens or vials from Lilly, with one approved formula |
| Studied in trials? | No | Yes, in the SURMOUNT trials |
| Self-pay price | $139 a month on 12 months, at every dose at NexLife | $299 to $449 a month by dose at LillyDirect ($449, from 7.5 mg, needs a refill within 45 days; otherwise $499 to $699) |
| Insurance | Usually paid in cash | Sometimes covered, often with prior authorization |
Prices checked November 1, 2026. Compounded tirzepatide is available only if your prescriber determines that it provides a significant difference for you compared to an FDA-approved product. Paying less for compounded tirzepatide or semaglutide somewhere else? NexLife matches your regular monthly price.†
- Tell us about you About 3 minutes of health questions
- A licensed provider decides You’re prescribed only if it’s right for you
- Your partner pharmacy ships Usually within 1 to 2 business days, free
Key takeaways
- Zepbound is FDA-approved brand-name tirzepatide: $299 a month at 2.5 mg through LillyDirect (checked November 1, 2026).
- From 7.5 mg up, Zepbound is $449 a month with a refill within 45 days, or $499 to $699.
- Compounded tirzepatide isn’t FDA-approved. A state-licensed pharmacy makes it for your prescription; it wasn’t studied in trials.
- Compounded costs less: $139 to $399 a month online in our price index, and its formula can differ by pharmacy.
- A first year: about $5,087 to $5,637 for Zepbound at LillyDirect, or $1,668 at NexLife on the 12-month plan.
- At NexLife: compounded tirzepatide is $139 a month on the 12-month plan, or $169 month to month, at every dose.
What tirzepatide costs per month at each provider
Medication+membership+shipping+dose increases=what you actually pay
All in means the medication plus every required recurring charge: membership, visit or program fee. Each bar is the monthly cost, month to month: dark is the starting price, light is the highest dose or the regular price after a sale. Prices checked November 1, 2026.
- Mochi$169/mo to startCompounded. Includes the $79 monthly membership. Medication is priced by dose, so the bill rises with yours.
- NexLife (ours)$169/mo month to monthPay less elsewhere? Matched†Compounded. No membership. The same price from 2.5 mg to 15 mg, or $139 a month on a 12-month plan.
- Ro$448 to $598/moBrand-name Zepbound. Includes the $149 monthly membership; $598 a month from 7.5 mg on the monthly plan.
- Hims$448/mo to startBrand-name Zepbound. Includes the $149 monthly membership after a $39 first month. Rises with dose.
- Embody$349/mo at every doseCompounded. Its regular month-to-month price, the same at every dose. It also advertises a lower sale price on its one-month supply and prepaid bundles. Rated 3.9 out of 5 on Trustpilot, from 11,253 reviews (read November 1, 2026).
- AltRx$149/mo advertisedCompounded. An advertised price, the same at every dose per its site; it doesn’t say how long you must commit.
- Refills$249/mo at every doseCompounded. All-inclusive per its site, shown against a struck-through $349; $159 a month on a 12-month plan.
- WeightWatchers ClinicNo all-in price publishedFDA-approved medicines only. Membership is $74 a month on a 12-month plan ($25 for each of the first two months for members who joined by November 3, 2026), and medication is extra, so there’s no all-in number to chart.
- LifeMDNo all-in price publishedBrand-name Zepbound or Wegovy. The program is $149 a month after a $39 first month; medication is extra.
- Remedy Meds$399 per 4 weeksCompounded. $399 every 4 weeks: 13 payments a year, about $432 a month.
Starting priceHighest dose or regular priceAdvertised price
Why the gaps are so wide. Brand-name programs cost more than compounded ones, and they aren’t the same product. The brand-name medicine is FDA-approved. Compounded medication isn’t, which means the FDA hasn’t reviewed it for safety, effectiveness or quality. Decide which one you want before you compare prices.
One price, every dose. NexLife is $139 a month on a 12-month plan, or $169 month to month, at the first dose and at the highest, all-inclusive, with no membership fee. Paying less with another licensed provider? We match it.†
Check my eligibilityCompounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.The numbers
What does a first year of brand-name or compounded tirzepatide cost?
| Route | First year |
|---|---|
| Zepbound through LillyDirect, moving up to 7.5 mg or more | $5,637 |
| Zepbound through LillyDirect, staying at 5 mg | $5,087 |
| Zepbound through a program with a $149 membership | About $7,315 |
| Zepbound through Medicare’s | $600 to $650 ($50 a fill) |
| Compounded tirzepatide at NexLife | $1,668 on a 12-month plan, or $2,028 month to month |
Zepbound: $299 at 2.5 mg, $399 at 5 mg, $449 from 7.5 mg to 15 mg with a refill within 45 days ($499 at 7.5 mg and $699 at 10 to 15 mg otherwise). Program total adds 12 months of a $149 membership, $39 the first month. Paying less for compounded tirzepatide or semaglutide somewhere else? NexLife matches your regular monthly price.†
NexLife Price Match Guarantee†. Already on compounded tirzepatide with another licensed provider, and paying less? We match your regular monthly price. How it works
In the FDA’s words
What does the FDA say about compounded tirzepatide?
Why the differences above matter, in the FDA’s own words.
“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”
U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers
“Compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug.”
U.S. Food and Drug Administration, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
“The drug product is compounded for an individual patient based on receipt of a prescription.”
U.S. Food and Drug Administration, on compounding under section 503A, FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
Brand-name or compounded? Choose the one you can stay on.
Only Zepbound is FDA-approved. Compounded tirzepatide costs less and is prepared by licensed 503A pharmacies. Here is how to choose with confidence.
- Coverage is limited. Many plans exclude weight-loss medicines, so for many people the cash price decides.
- Brand-name costs more. Zepbound through the online programs in our price index starts around $448 a month on a monthly membership.
- Consistency wins. The medicine that helps is the one you can keep taking.
Not just the cheaper option. The complete one.
- Named U.S. pharmacies. State-licensed 503A partner pharmacies: Absolute Pharmacy and Boudreaux’s New Drug Store.
- $139 a month on the 12-month plan, at every dose. Or $169 month to month, with care, coaching and shipping included.
- A provider decides with you. Your history, your goals and a dose that fits.
Real people to help you choose. A licensed provider reviews your history and helps you decide what fits. Call or text
Check my eligibilityCompounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.
Day to day
How is a tirzepatide pen different from a vial?
A pen does the measuring. Zepbound’s pens deliver a set dose. Nothing to draw up.
A vial asks you to measure. Compounded tirzepatide comes in a vial; you draw your dose with a syringe. Know it in milligrams, not units.
Strengths differ. Compounded vials vary by pharmacy, so the same dose can be a different number of units.
Help is a call away. At NexLife, questions about your vial go to us, 24/7, at
Your call
Which fits you better, Zepbound or compounded tirzepatide?
Zepbound may fit better if…
- Your insurance covers it, or you qualify for Medicare’s
GLP-1 Bridge - You want the FDA-approved medicine that was studied in trials
- You’d rather use a pen than draw doses from a vial
Compounded may fit better if…
- You’re paying cash and the price decides whether you can stay on treatment
- Your provider determines it offers a significant difference for you
- You want one flat price at every dose: $139 a month at NexLife on the 12-month plan
Your provider decides which is right for you. Next, read about compounded tirzepatide, Zepbound alternatives and switching from Zepbound to compounded tirzepatide.
Step by step
How do you choose between compounded tirzepatide and Zepbound?
Many plans exclude weight-loss medicines, so for many people the cash price decides. Weigh it against FDA approval, the evidence and the form.
- Check your coverage. Some plans cover Zepbound, usually with prior authorization, but many exclude weight-loss medicines. On Medicare Part D, the GLP-1 Bridge can bring it to $50 a month if you’re eligible.
- Compare FDA status. Zepbound is FDA-approved, with one approved formula from Lilly. Compounded tirzepatide isn’t FDA-approved, so the FDA hasn’t reviewed it for safety, effectiveness or quality, and its formula can differ by pharmacy.
- Look at the trial evidence. Compounded tirzepatide hasn’t been tested in clinical trials. In SURMOUNT-1, Zepbound’s highest dose led to 20.9% average weight loss over 72 weeks; that’s an average for Zepbound, not a promise.
- Compare the cash price. Zepbound is $299 to $449 a month at LillyDirect; $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699. At NexLife, compounded tirzepatide is $139 a month on the 12-month plan or $169 month to month.
- Choose a pen or a vial. Zepbound comes in pens or vials; a pen delivers a set dose, with nothing to draw up. Compounded tirzepatide comes in a multiple-dose vial you draw with a syringe, so know your dose in milligrams, not units.
- Let your provider decide. A licensed provider reviews your history and prescribes compounded tirzepatide only when it offers a significant difference for you. Switching from Zepbound is a change of product, and your provider decides your starting dose.
Steps 1 to 5 narrow the choice, with prices checked November 1, 2026; at step 6, your provider decides which is right for you.
What comes with compounded tirzepatide at NexLife?
LillyDirect sells Zepbound as medication only, and you bring your own prescriber. NexLife’s price, $139 a month on a 12-month plan or $169 month to month, includes the care around the medicine.
- A licensed providerIncluded, not separate. Your provider reviews your history and prescribes compounded tirzepatide only if it offers a significant difference for you.
- Real people, 24/7A vial, a dose or a delivery question goes to one number,
(949) 818-8000 . Physicians answer medical questions during clinical hours. - Nutrition plan and coachingA personalized nutrition plan and a 1:1 coaching call, which a medication-only purchase doesn’t include.
- Named partner pharmaciesCompounded for you by a state-licensed 503A pharmacy: Absolute Pharmacy or Boudreaux’s New Drug Store. Zepbound is made by Lilly.
- Free expedited shippingOrders usually ship within 1 to 2 business days, discreetly packed, at no charge.
- Pay your wayHSA and FSA cards, plus pay-later options at checkout.
One number for everything.
A question about your vial, a package that arrived warm, a dose that feels wrong: call or text us 24/7 at
Vial math
How many units is your tirzepatide dose?
It depends on your vial’s strength. Here are the label’s doses at one example strength, with the math to check your own.
| Dose | mL at 25 mg/mL | Units (U-100) | On the label |
|---|---|---|---|
| 2.5 mg | 0.1 mL | 10 units | Starting dose, for 4 weeks |
| 5 mg | 0.2 mL | 20 units | A maintenance dose |
| 7.5 mg | 0.3 mL | 30 units | A step up |
| 10 mg | 0.4 mL | 40 units | A maintenance dose |
| 12.5 mg | 0.5 mL | 50 units | A step up |
| 15 mg | 0.6 mL | 60 units | The maximum, and a maintenance dose |
The math: mL = dose ÷ strength (mg per mL), and units = mL × 100. At 25 mg/mL, 10 mg is 10 ÷ 25 = 0.4 mL, or 40 units.
25 mg per mL is an example only: it’s the strength of the 15 mg multi-dose vial on Zepbound’s label (15 mg per 0.6 mL). Read the strength on your own vial’s label; your provider sets your dose, in steps at least 4 weeks apart. Every step: the tirzepatide dosage chart.
What would you pay with NexLife?
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Prices from each provider’s own site, checked November 1, 2026. Brand-name and compounded medications are different products: compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you. Price Match Guarantee† terms apply.
What does NexLife cost?
One flat price at every dose.
No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†
GIP + 12-month plan $139/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication
12-month plan $119/mo
Semaglutide
Weekly
Compounded, not FDA-approved · Not prescribed? No charge for medication
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms
The NexLife Price Match Guarantee†
Paying less elsewhere?
Keep your price. Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Compounded vs. brand-name tirzepatide: your questions
Fair questions about NexLife
- Will my price go up with my dose?
- No. You pay the same at every dose.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
Is compounded tirzepatide the same as Zepbound?
No. Zepbound is Eli Lilly’s FDA-approved tirzepatide, studied in the SURMOUNT trials, with one approved formula in pens or vials. Compounded tirzepatide is prepared by a state-licensed pharmacy for your prescription, usually in a multiple-dose vial. It isn’t FDA-approved, wasn’t studied in trials, and its formula can differ by pharmacy.
Is there a generic version of Zepbound?
No. The only FDA-approved tirzepatide in the U.S. is Eli Lilly’s: Zepbound for weight loss and Mounjaro for type 2 diabetes. Compounded tirzepatide is a different product. A state-licensed pharmacy prepares it for your prescription, and it isn’t FDA-approved. A provider prescribes it only when it offers a significant difference for you compared with an FDA-approved product.
Why is compounded tirzepatide cheaper?
It isn’t a brand-name drug; a state-licensed pharmacy makes it for you. It runs $139 to $399 a month in our price index, all in, while Zepbound’s medication alone is $299 to $449 at LillyDirect (checked November 1, 2026); the $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699. NexLife: $139 a month on the 12-month plan.
Does compounded tirzepatide work as well as Zepbound?
There’s no direct evidence either way: compounded tirzepatide hasn’t been tested in clinical trials. Trials such as SURMOUNT-1 (20.9% average weight loss at the highest dose over 72 weeks) studied FDA-approved Zepbound. Compounded tirzepatide isn’t FDA-approved, so the FDA hasn’t reviewed it for safety, effectiveness or quality, and its formula can differ by pharmacy.
Can I switch from Zepbound to compounded tirzepatide?
Often, yes, after a provider reviews your history. It’s a change of product, not just price: a provider prescribes compounded tirzepatide only when it offers a significant difference for you, and decides your starting dose. It usually comes in a multiple-dose vial you draw with a syringe. More: switching from Zepbound to compounded tirzepatide.
Is Zepbound covered by insurance?
Sometimes. Some plans cover Zepbound, usually with prior authorization, but many exclude weight-loss medicines, so for many people the cash price decides. On Medicare Part D, the
What’s the difference between a tirzepatide pen and a vial?
A pen delivers a set dose, with nothing to draw up. A vial holds several doses that you draw with a syringe, so you need to know your dose in milligrams, not units. Zepbound comes in pens or vials from Lilly; compounded tirzepatide comes in a multiple-dose vial, and strengths differ by pharmacy.
Which one does NexLife offer?
Compounded tirzepatide. NexLife doesn’t prescribe brand-name Zepbound. It’s $139 a month on the 12-month plan or $169 month to month, the same at every dose, prepared by a state-licensed 503A partner pharmacy: Absolute Pharmacy or Boudreaux’s New Drug Store. A licensed provider prescribes it only when it offers a significant difference for you.
What is the brand name of tirzepatide?
Tirzepatide’s brand names are Zepbound and Mounjaro, both FDA-approved and made by Eli Lilly. Zepbound is for weight loss and obstructive sleep apnea; Mounjaro is for type 2 diabetes. Compounded tirzepatide is a different product: a state-licensed pharmacy prepares it for your prescription, and it isn’t FDA-approved.
How much does Zepbound cost without insurance?
Zepbound costs $299 to $449 a month self-pay at LillyDirect (checked November 1, 2026): $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg with a refill within 45 days, or $499 to $699. At NexLife, compounded tirzepatide, which isn’t FDA-approved, is $139 a month on the 12-month plan, or $169 month to month.
Is compounded tirzepatide as safe as Zepbound?
No one can say for sure: compounded tirzepatide hasn’t been tested in clinical trials, and because it isn’t FDA-approved, the FDA hasn’t reviewed it for safety, effectiveness or quality. Trials such as SURMOUNT-1 studied FDA-approved Zepbound. The FDA says compounded drugs should only be used when an approved drug can’t meet a patient’s medical needs.
Does LillyDirect include a prescriber for Zepbound?
No. LillyDirect sells Zepbound as medication only, and you bring your own prescriber. NexLife’s price, $139 a month on a 12-month plan or $169 month to month, includes the care around the medicine, such as a nutrition plan and a 1:1 coaching call. It’s for compounded tirzepatide, which isn’t FDA-approved.
Why does Zepbound cost more through Ro or Hims than at LillyDirect?
Their prices include a $149 monthly membership on top of the medication. Ro is $448 to $598 a month, and Hims starts at $448 after a $39 first month. LillyDirect sells Zepbound as medication only, and you bring your own prescriber.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
“No. A generic drug is approved by FDA under 505(j) of the FD&C Act and meets all of the requirements of that section (including establishing therapeutic equivalence to a brand name drug, among others), while a compounded drug is not approved by FDA.”
Who wrote and medically reviewed this page?
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
Zepbound’s label and SURMOUNT-1 results, LillyDirect’s self-pay prices, the Medicare
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Paying less elsewhere? We match it.†
$139 a month on 12 months. Every dose. All in.
$139 a month on a 12-month plan, or $169 month to month. Start online in about 3 minutes. A licensed provider decides if compounded tirzepatide is right for you.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
Start online with your health history.
- 2A licensed provider decides
Online, following your state’s rules. You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
- The New England Journal of Medicine. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1), 2022.
- Eli Lilly and Company. Zepbound through LillyDirect.
- KFF. What to know about the BALANCE Model and the Medicare
GLP-1 Bridge (updated May 11, 2026). - U.S. Food and Drug Administration. FDA’s concerns with unapproved
GLP-1 drugs used for weight loss. - NexLife. Compounded tirzepatide plans.
- Novo Nordisk. Wegovy (semaglutide) prescribing information.
- LegitScript. LegitScript certification record for NexLife.us.
- NexLife. Compounded semaglutide plans.
- Ro: weight loss program pricing. Checked November 1, 2026.
- Hims: Zepbound KwikPen. Checked November 1, 2026.
- Hims: Wegovy pill and pen, with membership. Checked November 1, 2026.
- Mochi Health: FAQs (membership and medication prices). Checked November 1, 2026.
- Embody: compounded tirzepatide, one-month supply. Checked November 1, 2026.
- Embody: compounded semaglutide, one-month supply. Checked November 1, 2026.
- NexLife.
GLP-1 price index (sources for every program). Checked November 1, 2026. - U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
- U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.